Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Sep;71(9):6359–6372. doi: 10.1128/jvi.71.9.6359-6372.1997

Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection.

R T Kilani 1, L J Chang 1, M I Garcia-Lloret 1, D Hemmings 1, B Winkler-Lowen 1, L J Guilbert 1
PMCID: PMC191909  PMID: 9261353

Abstract

Whether cell-free human immunodeficiency virus type 1 (HIV-1) can productively infect placental trophoblasts (which in turn could transmit the virus into the fetal circulation) is controversial but essential to know for the evaluation of alternative routes (such as cell-mediated infection or trophoblast damage). We have addressed infection factors such as cell purity, source, culture methods, and activation states as well as virus variant and detection methods to conclusively determine the outcome of trophoblast challenge by free virus. Pure (> 99.98%) populations of trophoblasts from 11 different placentas were challenged at a multiplicity of infection (MOI) as high as 6 with five different HIV-1 variants, three of which are non-syncytium-forming, macrophage-tropic isolates from infected infants, with and without coinfection with cytomegalovirus; these preparations were monitored for productive infection for up to 3 weeks after challenge by five different criteria, the most sensitive of which were cocultivation with target cells that can detect virus at an MOI of 10(-7) and HIV DNA PCR that detects 30 virus copies per 10(5) cells. Infection was never detected. However, molecularly cloned T-cell (pNL4-3)- and macrophage (pNLAD8)-tropic provirus plasmids, when transfected into primary trophoblasts, yielded productive infections, indicating that trophoblasts do not suppress late-stage virus replication and assembly. Because of the purity of the trophoblast preparations, the extended length of the infection culture period, the number of trophoblast preparations and virus types examined, the sensitivity of the bioassays and molecular detection assays, and the observations that trophoblasts can support virus replication from provirus, the results of this study strongly argue that free virus cannot infect primary villous trophoblasts.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986 Aug;59(2):284–291. doi: 10.1128/jvi.59.2.284-291.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams M., Sharmeen L., Kimpton J., Romeo J. M., Garcia J. V., Peterlin B. M., Groudine M., Emerman M. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3862–3866. doi: 10.1073/pnas.91.9.3862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahmad N., Baroudy B. M., Baker R. C., Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol. 1995 Feb;69(2):1001–1012. doi: 10.1128/jvi.69.2.1001-1012.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aplin J. D. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci. 1991 Aug;99(Pt 4):681–692. doi: 10.1242/jcs.99.4.681. [DOI] [PubMed] [Google Scholar]
  5. Backé E., Jimenez E., Unger M., Schäfer A., Vocks-Hauck M., Grosch-Wörner I., Vogel M. Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatol. 1994 Sep;11(5):326–330. doi: 10.1055/s-2007-994545. [DOI] [PubMed] [Google Scholar]
  6. Backé E., Jiménez E., Unger M., Schäfer A., Jauniaux E., Vogel M. Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol. 1992 Oct;45(10):871–874. doi: 10.1136/jcp.45.10.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bagasra O., Pomerantz R. J. Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction. AIDS Res Hum Retroviruses. 1993 Jan;9(1):69–76. doi: 10.1089/aid.1993.9.69. [DOI] [PubMed] [Google Scholar]
  8. Bertolli J., St Louis M. E., Simonds R. J., Nieburg P., Kamenga M., Brown C., Tarande M., Quinn T., Ou C. Y. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis. 1996 Oct;174(4):722–726. doi: 10.1093/infdis/174.4.722. [DOI] [PubMed] [Google Scholar]
  9. Bourinbaiar A. S., Krasinski K., Borkowsky W., Lee-Huang S. Protective effect of interferon-alpha against cell-mediated human immunodeficiency virus transmission resulting from coculture of infected lymphocytes with fetal trophoblasts. J Interferon Cytokine Res. 1995 Jun;15(6):503–508. doi: 10.1089/jir.1995.15.503. [DOI] [PubMed] [Google Scholar]
  10. Bourinbaiar A. S., Nagorny R. Human immunodeficiency virus type 1 infection of choriocarcinoma-derived trophoblasts. Acta Virol. 1993 Feb;37(1):21–28. [PubMed] [Google Scholar]
  11. Boyer P. J., Dillon M., Navaie M., Deveikis A., Keller M., O'Rourke S., Bryson Y. J. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994 Jun 22;271(24):1925–1930. [PubMed] [Google Scholar]
  12. Bryson Y. J., Luzuriaga K., Sullivan J. L., Wara D. W. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992 Oct 22;327(17):1246–1247. doi: 10.1056/NEJM199210223271718. [DOI] [PubMed] [Google Scholar]
  13. Chaffee S., Leeds J. M., Matthews T. J., Weinhold K. J., Skinner M., Bolognesi D. P., Hershfield M. S. Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med. 1988 Aug 1;168(2):605–621. doi: 10.1084/jem.168.2.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chandwani S., Greco M. A., Mittal K., Antoine C., Krasinski K., Borkowsky W. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis. 1991 May;163(5):1134–1138. doi: 10.1093/infdis/163.5.1134. [DOI] [PubMed] [Google Scholar]
  15. Chang J., Li S., Naif H., Cunningham A. L. The magnitude of HIV replication in monocytes and macrophages is influenced by environmental conditions, viral strain, and host cells. J Leukoc Biol. 1994 Sep;56(3):230–235. doi: 10.1002/jlb.56.3.230. [DOI] [PubMed] [Google Scholar]
  16. Chang L. J., McNulty E., Martin M. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J Virol. 1993 Feb;67(2):743–752. doi: 10.1128/jvi.67.2.743-752.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chang L. J., Zhang C. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Virology. 1995 Aug 1;211(1):157–169. doi: 10.1006/viro.1995.1388. [DOI] [PubMed] [Google Scholar]
  18. Chesebro B., Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol. 1988 Oct;62(10):3779–3788. doi: 10.1128/jvi.62.10.3779-3788.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol. 1992 Nov;66(11):6547–6554. doi: 10.1128/jvi.66.11.6547-6554.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. D'Andrea S., Chousterman S., Flechon J. E., La Bonnardière C. Paracrine activities of porcine trophoblastic interferons. J Reprod Fertil. 1994 Sep;102(1):185–194. doi: 10.1530/jrf.0.1020185. [DOI] [PubMed] [Google Scholar]
  21. David F. J., Autran B., Tran H. C., Menu E., Raphael M., Debre P., Hsi B. L., Wegman T. G., Barre-Sinoussi F., Chaouat G. Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol. 1992 Apr;88(1):10–16. doi: 10.1111/j.1365-2249.1992.tb03031.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. David F. J., Tran H. C., Serpente N., Autran B., Vaquero C., Djian V., Menu E., Barré-Sinoussi F., Chaouat G. HIV infection of choriocarcinoma cell lines derived from human placenta: the role of membrane CD4 and Fc-Rs into HIV entry. Virology. 1995 Apr 20;208(2):784–788. doi: 10.1006/viro.1995.1212. [DOI] [PubMed] [Google Scholar]
  23. De Andreis C., Simoni G., Rossella F., Castagna C., Pesenti E., Porta G., Colucci G., Giuntelli S., Pardi G., Semprini A. E. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis. AIDS. 1996 Jun;10(7):711–715. doi: 10.1097/00002030-199606001-00004. [DOI] [PubMed] [Google Scholar]
  24. Douglas G. C., Fry G. N., Thirkill T., Holmes E., Hakim H., Jennings M., King B. F. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses. 1991 Sep;7(9):735–740. doi: 10.1089/aid.1991.7.735. [DOI] [PubMed] [Google Scholar]
  25. Douglas G. C., King B. F. Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J Cell Sci. 1990 May;96(Pt 1):131–141. doi: 10.1242/jcs.96.1.131. [DOI] [PubMed] [Google Scholar]
  26. Dunn D. T., Newell M. L., Ades A. E., Peckham C. S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 Sep 5;340(8819):585–588. doi: 10.1016/0140-6736(92)92115-v. [DOI] [PubMed] [Google Scholar]
  27. Fazely F., Fry G. N., Thirkill T. L., Hakim H., King B. F., Douglas G. C. Kinetics of HIV infection of human placental syncytiotrophoblast cultures: an ultrastructural and immunocytochemical study. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1023–1030. doi: 10.1089/aid.1995.11.1023. [DOI] [PubMed] [Google Scholar]
  28. Garcia-Lloret M. I., Yui J., Winkler-Lowen B., Guilbert L. J. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol. 1996 May;167(2):324–332. doi: 10.1002/(SICI)1097-4652(199605)167:2<324::AID-JCP17>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  29. Garcia J. A., Harrich D., Soultanakis E., Wu F., Mitsuyasu R., Gaynor R. B. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 1989 Mar;8(3):765–778. doi: 10.1002/j.1460-2075.1989.tb03437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  31. Guilbert L., Robertson S. A., Wegmann T. G. The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol. 1993 Feb;71(Pt 1):49–57. doi: 10.1038/icb.1993.5. [DOI] [PubMed] [Google Scholar]
  32. Hassan N. F., Campbell D. E., Douglas S. D. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods. 1986 Dec 24;95(2):273–276. doi: 10.1016/0022-1759(86)90415-1. [DOI] [PubMed] [Google Scholar]
  33. Jault F. M., Spector S. A., Spector D. H. The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol. 1994 Feb;68(2):959–973. doi: 10.1128/jvi.68.2.959-973.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kesson A. M., Fear W. R., Williams L., Chang J., King N. J., Cunningham A. L. HIV infection of placental macrophages: their potential role in vertical transmission. J Leukoc Biol. 1994 Sep;56(3):241–246. doi: 10.1002/jlb.56.3.241. [DOI] [PubMed] [Google Scholar]
  35. Kliks S. C., Wara D. W., Landers D. V., Levy J. A. Features of HIV-1 that could influence maternal-child transmission. JAMA. 1994 Aug 10;272(6):467–474. [PubMed] [Google Scholar]
  36. Kliman H. J., Nestler J. E., Sermasi E., Sanger J. M., Strauss J. F., 3rd Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology. 1986 Apr;118(4):1567–1582. doi: 10.1210/endo-118-4-1567. [DOI] [PubMed] [Google Scholar]
  37. Koval V., Jault F. M., Pal P. G., Moreno T. N., Aiken C., Trono D., Spector S. A., Spector D. H. Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol. 1995 Mar;69(3):1645–1651. doi: 10.1128/jvi.69.3.1645-1651.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lairmore M. D., Cuthbert P. S., Utley L. L., Morgan C. J., Dezzutti C. S., Anderson C. L., Sedmak D. D. Cellular localization of CD4 in the human placenta. Implications for maternal-to-fetal transmission of HIV. J Immunol. 1993 Aug 1;151(3):1673–1681. [PubMed] [Google Scholar]
  39. Lathey J. L., Spector D. H., Spector S. A. Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology. 1994 Feb 15;199(1):98–104. doi: 10.1006/viro.1994.1101. [DOI] [PubMed] [Google Scholar]
  40. Lori F., di Marzo Veronese F., de Vico A. L., Lusso P., Reitz M. S., Jr, Gallo R. C. Viral DNA carried by human immunodeficiency virus type 1 virions. J Virol. 1992 Aug;66(8):5067–5074. doi: 10.1128/jvi.66.8.5067-5074.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Luzuriaga K., McQuilken P., Alimenti A., Somasundaran M., Hesselton R., Sullivan J. L. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Dis. 1993 May;167(5):1008–1013. doi: 10.1093/infdis/167.5.1008. [DOI] [PubMed] [Google Scholar]
  42. Lyman W. D. Perinatal AIDS: drugs of abuse and transplacental infection. Adv Exp Med Biol. 1993;335:211–217. doi: 10.1007/978-1-4615-2980-4_29. [DOI] [PubMed] [Google Scholar]
  43. Martin A. W., Brady K., Smith S. I., DeCoste D., Page D. V., Malpica A., Wolf B., Neiman R. S. Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissue. Hum Pathol. 1992 Apr;23(4):411–414. doi: 10.1016/0046-8177(92)90088-k. [DOI] [PubMed] [Google Scholar]
  44. Mattern C. F., Murray K., Jensen A., Farzadegan H., Pang J., Modlin J. F. Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics. 1992 Feb;89(2):207–209. [PubMed] [Google Scholar]
  45. Maury W., Potts B. J., Rabson A. B. HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis. 1989 Oct;160(4):583–588. doi: 10.1093/infdis/160.4.583. [DOI] [PubMed] [Google Scholar]
  46. McCune J. M. Viral latency in HIV disease. Cell. 1995 Jul 28;82(2):183–188. doi: 10.1016/0092-8674(95)90305-4. [DOI] [PubMed] [Google Scholar]
  47. McGann K. A., Collman R., Kolson D. L., Gonzalez-Scarano F., Coukos G., Coutifaris C., Strauss J. F., Nathanson N. Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis. 1994 Apr;169(4):746–753. doi: 10.1093/infdis/169.4.746. [DOI] [PubMed] [Google Scholar]
  48. Mikovits J. A., Lohrey N. C., Schulof R., Courtless J., Ruscetti F. W. Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest. 1992 Oct;90(4):1486–1491. doi: 10.1172/JCI116016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Morrish D. W., Bhardwaj D., Dabbagh L. K., Marusyk H., Siy O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab. 1987 Dec;65(6):1282–1290. doi: 10.1210/jcem-65-6-1282. [DOI] [PubMed] [Google Scholar]
  50. Osborn L., Kunkel S., Nabel G. J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336–2340. doi: 10.1073/pnas.86.7.2336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Peckham C. S. Human immunodeficiency virus infection and pregnancy. Sex Transm Dis. 1994 Mar-Apr;21(2 Suppl):S28–S31. [PubMed] [Google Scholar]
  52. Peterson P. K., Gekker G., Chao C. C., Hu S. X., Edelman C., Balfour H. H., Jr, Verhoef J. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest. 1992 Feb;89(2):574–580. doi: 10.1172/JCI115623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Phillips D. M., Tan X. HIV-1 infection of the trophoblast cell line BeWo: a study of virus uptake. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1683–1691. doi: 10.1089/aid.1992.8.1683. [DOI] [PubMed] [Google Scholar]
  54. Popik W., Pitha P. M. Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. J Virol. 1993 Feb;67(2):1094–1099. doi: 10.1128/jvi.67.2.1094-1099.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Poulin L., Paquette N., Moir S., Lapointe R., Darveau A. Productive infection of normal CD40-activated human B lymphocytes by HIV-1. AIDS. 1994 Nov;8(11):1539–1544. doi: 10.1097/00002030-199411000-00004. [DOI] [PubMed] [Google Scholar]
  56. Reinhardt P. P., Reinhardt B., Lathey J. L., Spector S. A. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates. J Clin Microbiol. 1995 Feb;33(2):292–297. doi: 10.1128/jcm.33.2.292-297.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rich E. A., Chen I. S., Zack J. A., Leonard M. L., O'Brien W. A. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest. 1992 Jan;89(1):176–183. doi: 10.1172/JCI115559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Scheglovitova O., Capobianchi M. R., Antonelli G., Guanmu D., Dianzani F. CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells. Arch Virol. 1993;132(3-4):267–280. doi: 10.1007/BF01309538. [DOI] [PubMed] [Google Scholar]
  59. Schuitemaker H., Kootstra N. A., Koppelman M. H., Bruisten S. M., Huisman H. G., Tersmette M., Miedema F. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest. 1992 Apr;89(4):1154–1160. doi: 10.1172/JCI115697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Schwartz D. H., Sharma U. K., Perlman E. J., Blakemore K. Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells: a model of maternal --> fetal transmission. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):978–982. doi: 10.1073/pnas.92.4.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Temmerman M., Nyong'o A. O., Bwayo J., Fransen K., Coppens M., Piot P. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):700–705. doi: 10.1016/0002-9378(95)90597-9. [DOI] [PubMed] [Google Scholar]
  62. Tóth F. D., Mosborg-Petersen P., Kiss J., Aboagye-Mathiesen G., Hager H., Juhl C. B., Gergely L., Zdravkovic M., Aranyosi J., Lampé L. Interactions between human immunodeficiency virus type 1 and human cytomegalovirus in human term syncytiotrophoblast cells coinfected with both viruses. J Virol. 1995 Apr;69(4):2223–2232. doi: 10.1128/jvi.69.4.2223-2232.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Tóth F. D., Mosborg-Petersen P., Kiss J., Aboagye-Mathiesen G., Zdravkovic M., Hager H., Aranyosi J., Lampé L., Ebbesen P. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro. Clin Exp Immunol. 1994 Jun;96(3):389–394. doi: 10.1111/j.1365-2249.1994.tb06040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Vicenzi E., Poli G. Regulation of HIV expression by viral genes and cytokines. J Leukoc Biol. 1994 Sep;56(3):328–334. doi: 10.1002/jlb.56.3.328. [DOI] [PubMed] [Google Scholar]
  65. Webster A. Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr. 1991;4 (Suppl 1):S47–S52. [PubMed] [Google Scholar]
  66. Xiao J., Garcia-Lloret M., Winkler-Lowen B., Miller R., Simpson K., Guilbert L. J. ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol. 1997 May;150(5):1845–1860. [PMC free article] [PubMed] [Google Scholar]
  67. Yui J., Garcia-Lloret M., Brown A. J., Berdan R. C., Morrish D. W., Wegmann T. G., Guilbert L. J. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta. 1994 Apr;15(3):231–246. doi: 10.1016/0143-4004(94)90015-9. [DOI] [PubMed] [Google Scholar]
  68. Zachar V., Nørskov-Lauritsen N., Juhl C., Spire B., Chermann J. C., Ebbesen P. Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol. 1991 Jun;72(Pt 6):1253–1260. doi: 10.1099/0022-1317-72-6-1253. [DOI] [PubMed] [Google Scholar]
  69. Zachar V., Thomas R. A., Jones T., Goustin A. S. Vertical transmission of HIV: detection of proviral DNA in placental trophoblast. AIDS. 1994 Jan;8(1):129–130. [PubMed] [Google Scholar]
  70. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990 Apr 20;61(2):213–222. doi: 10.1016/0092-8674(90)90802-l. [DOI] [PubMed] [Google Scholar]
  71. van't Wout A. B., Kootstra N. A., Mulder-Kampinga G. A., Albrecht-van Lent N., Scherpbier H. J., Veenstra J., Boer K., Coutinho R. A., Miedema F., Schuitemaker H. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest. 1994 Nov;94(5):2060–2067. doi: 10.1172/JCI117560. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES